Small Molecules

24 Feb 2007 Satraplatin Shown to Significantly Reduce Risk of Disease Progression in Advanced Hormone-Refractory Prostate Cancer Patients
24 Feb 2007 Oral cancer drug Xeloda receives positive opinion from the European Authorities for the treatment of advanced gastric cancer
24 Feb 2007 SEBIVO(R) (telbivudine) Recommended for Approval in European Union as a new Treatment for Patients with Chronic Hepatitis B
24 Feb 2007 Positive AS1404 trial data presented at ASCO Prostate Cancer Symposium
24 Feb 2007 GTx's ACAPODENE Interim Bone Mineral Density and Lipid Data Highlighted at Press Briefing at Prostate Cancer Symposium of the American Society of Clinical Oncology
24 Feb 2007 Cougar Biotechnology Announces Presentation of Positive Phase I and Phase II Data at ASCO Prostate Cancer Symposium
23 Feb 2007 Phase II Cystic Fibrosis Study Closes Enrollment
23 Feb 2007 Callisto Pharmaceuticals Opens L-Annamycin Phase I Clinical Trial in Pediatric Relapsed or Refractory Acute Leukemia
23 Feb 2007 Hollis-Eden Pharmaceuticals Presents Additional Positive Data with Novel Steroid Hormone in Models of Prostate and Breast Cancer
23 Feb 2007 Valeant Pharmaceuticals Files Investigational New Drug Application for Cesamet(R) in Cancer Chemotherapy-Induced Neuropathic Pain
23 Feb 2007 Auris Medical initiating phase I/II clinical trial with AM-101
22 Feb 2007 Pharmacyclics Receives Refuse to File Letter for Xcytrin
22 Feb 2007 Manhattan Pharmaceuticals, Inc. Completes Enrollment In Phase 2a Study Of Oral Oleoyl-estrone For Obesity
22 Feb 2007 Sosei Announces Progression of SD118 Towards Phase 1 Studies
22 Feb 2007 Allegiance Equity Corporation Announces Positive Results of In Vitro Studies and an Open Label Trial for Relieva(R) in Treating Atopic Dermatitis
22 Feb 2007 Landark study shows important benefits of Seretide(TM) mtreatment for patients with fatal lung disease, COPD
21 Feb 2007 BioMarin Announces Results From Phase 2 Clinical Study of 6R-BH4 in Poorly Controlled Hypertension
21 Feb 2007 Lux Biosciences Initiates LUMINATE Pivotal Clinical Trials of Its Next-Generation Calcineurin Inhibitor, LX211, in Uveitis
21 Feb 2007 Roche and GSK agree on two transactions
21 Feb 2007 Avalon Pharmaceuticals Announces the Initiation of Drug Discovery Program for the MYC Oncoprotein - One of the Most Important and Intractable Cancer Targets
21 Feb 2007 Alteon's Investigational Drug Alagebrium Demonstrates Ability to Improve Functional Membrane Transport in a Rat Model of Chronic Peritoneal Dialysis, Indicating a Potential Role in Kidney Disease
21 Feb 2007 Novacea's ASCENT Phase 2 Trial Published in the Journal of Clinical Oncology
21 Feb 2007 Theravance Announces FDA Acceptance of Telavancin NDA
21 Feb 2007 Hana Biosciences Reports Likely Delay in Launch of Zensana
20 Feb 2007 Basilea Reports Positive Phase III Results for Alitretinoin

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up